
The Smartest Stock to Buy for Under $50 Now
Published on March 15, 2023
Pharma giant Pfizer (PFE) had a successful fiscal year 2022 with record-breaking revenue and earnings. Moreover, its recent acquisition should boost its portfolio and revenue. Given the market volatility, this...
